Survival analysis was done by spss software for windows version 16. Subependymal hamartomas are seen in patients with tuberous sclerosis. Subependymal giant cell astrocytoma with high cholinecreatine. Differential diagnosis of brain ventricular and subependymal. It is one of the intracranial lesions found in tuberous sclerosis complex which include subependymal nodules, cortical tubers, retinal astrocytoma and subependymal giant cell astrocytoma, but cases without such lesions have also been. Subependymal giantcell astrocytomas, which are slowgrowing, glioneuronal tumors typically arising near the foramen of monro, 5,6 develop in 5 to 20% of patients with the tuberous sclerosis. This is because astrocytes are a type of glial cell. To date, no radiographic features have been identified that will accurately predict which subependymal nodules will grow and require treatment. Aug 24, 2014 subependymal nodules f ound on the walls of the lateral ventricles and are either discrete or roughly confluent areas of round ed hypertrophic tissue. The prevalence rate of tsc in patients with sega ranges from 5% to 20%.
The diagnosis and treatment of subependymal giant cell astrocytoma combined with tuberous sclerosis article pdf available in child s nervous system 271. Subependymal giant cell astrocytoma presenting with tumoral. Subependymal nodules are detected in 95% of patients. Subependymal hamartoma radiology reference article. Subependymal giant cell astrocytoma is the most common cns neoplasm associated with the tuberous sclerosis complex. Subependymal nodules f ound on the walls of the lateral ventricles and are either discrete or roughly confluent areas of round ed hypertrophic tissue. Clinical and imaging features of subependymal giant cell astrocytoma. Definition of subependymal giant cell astrocytoma nci. Resection of subependymal giant cell astrocytoma guided by. Most subependymal giant cell astrocytomas will show avid enhancement after contrast administration.
Imaging manifestations of a subependymal giant cell. National library of medicine drug information portal medline plus health information. Imaging and morphologic features of sporadic subependymal giant cell astrocytomalike astrocytoma. Pleomorphic xanthoastrocytomas are typically supratentorial, cortically based masses with strong heterogeneous enhancement. Subependymal giant cell astrocytoma is a rare, benign glioneural tumor arising in a subset of patients with tuberous sclerosis, a genetic disease that involves mutations of proteins occurring in tumor suppression.
Although it is a lowgrade tumor, its location can potentially obstruct the ventricles and lead to hydrocephalus. Astrocytoma causes regional effects by compression, invasion, and destruction of brain parenchyma, arterial and venous hypoxia, competition for nutrients, release of metabolic end products e. Subependymal giant cell astrocytoma sega symptoms and. Oct 24, 2015 subependymal giant cell astrocytomas are typically near the foramen of monro and usually occur in patients with tuberous sclerosis. To report a case of subependymal giant cell astrocytoma sega in a.
Everolimus for subependymal giantcell astrocytomas in. Subependymal giant cell astrocytoma libre pathology. The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex. Sudden death in epilepsy due to an isolated subependymal giant cell astrocytoma of the septum pellucidum. The tumor cells share features of glial cells and are immunoreactive for glial fibrillary acidic protein b, c but also have neuronal features and are immunopositive for.
We present 19 patients with tuberous sclerosis complex and subependymal giant cell astrocytoma. Tsc is an autosomal dominantly inherited neurocutaneous syndrome that affects any organ system of the body. Subependymal giant cell astrocytomas sgcas or alternatively segas are benign tumors who grade i, seen almost exclusively in young patients with tuberous sclerosis. The clinical characteristics of subependymal giant cell astrocytoma.
Subependymal giant cell tumors are a wellknown manifestation of tuberous sclerosis, affecting 515% of patients with the condition 8. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis r nabbout, m santos, y rolland, o delalande, o dulac, c chiron abstract objectivesintraventricular astrocytomas subependymal giant cell astrocytomas of tuberous sclerosis have a poor prognosis due to the obstruction of csf. It is most commonly associated with tuberous sclerosis complex tsc. We assessed the efficacy and safety of everolimus in patients with subependymal giant cell astrocytomas associated with tuberous sclerosis complex. Thyroid transcription factor1 distinguishes subependymal. Pathology outlines subependymal giant cell astrocytoma sega. One case developed in the absence of clinical features of neurofibromatosis type1. Noncontrast axial 3d t1weighted imaging is similar to contrastenhanced axial 3d t1weighted imaging for subependymal giant cell astrocytoma size measurement. This research was supported by basic science research program through the national. Subependymal giant cell astrocytoma grade i brain tumor. Subependymal giant cell astrocytoma presenting with. The imaging findings of this patient are suggestive of a subependymal giant cell astrocytoma versus a subependymal nodule based on its incomplete calcification, enhancement with gadolinium, and size 1 cm. Surgical resection is recommended in this situation.
Loss of either protein leads to overgrowth in many organs, including subependymal nodules, subependymal giant cell astrocytomas. Subependymal giant cell astrocytoma shows large mostly polygonal cells with abundant cytoplasm and often vesicular eccentric nucleus with prominent nucleolus a. Two radiologists evaluated the location, shape, size, number, edge, cerebral edema, homogeneous or. In an openlabel, phase 12 study, the mtor inhibitor everolimus substantially and significantly reduced the volume of subependymal giant cell astrocytomas. Loss of either protein leads to overgrowth in many organs, including subependymal nodules, subependymal giant cell. Early diagnosis of subependymal giant cell astrocytoma in. They are principally diagnosed in patients under 20 years of age, only occasionally found in older individuals. Decreasing incidence of sudden death due to undiagnosed primary central nervous system tumors neuroimaging results were available in 115 infants, of whom 94% had tubers or cortical dysplasias, 90% had sens, and 89% had both. Imaging and morphologic features of sporadic subependymal giant cell astrocytoma like astrocytoma. We report a rare case of subependymal giant cell astrocytoma sega. Surgical resection remains the recommended treatment for symptomatic segas. Subependymal giant cell astrocytomalike astrocytoma. Subependymal giant cell astrocytoma sega is a rare tumor occurring almost.
As with other hamartomas, they grow at the same rate as the surrounding tissues on imaging, they appear as small intraventricular masses, smaller than 1 cm, and demonstrate variable signal on mri with contrast enhancement, and may calcify. Subependymal nodule subependymal giant cell astrocytoma cardiac rhabdomyoma, single or multiple lymphangiomatosis renal angiomyolipoma minor features. The tumors are made up of large, starshaped cells called astrocytes. Subependymal giant cell astrocytomas are a specific type of astrocytoma, and also belong to the broader category of gliomas tumors that arise from glial cells. Modern pathology thyroid transcription factor1 distinguishes subependymal giant cell astrocytoma from its mimics and supports its cell origin from the progenitor cells in the medial ganglionic eminence jenfan hang 0 1 3 chihyi hsu 0 1 3 shihchieh lin 0 1 3 chihchun wu 2 3 hanjui lee 2 3 donald mingtak ho 0 1 3 0 department of pathology and laboratory medicine, taipei veterans general. Diagnosing subependymal giant cell astrocytoma testing to diagnose subependymal giant cell astrocytoma. Idepartments of diagnostic radiology, university of parana school of medicine. In doubtful cases, ct imaging may promptly differentiate haemosiderin from calcium deposits. Case report imaging manifestations of a subependymal giant. This study was supported by the basic science research program through the. Like most brain tumors, subependymal giant cell astrocytomas sega are diagnosed through imaging studies such as mri or ct scans. On imaging, they classically appear as an intraventricular mass. For this reason, subependymal giant cell astrocytoma grade i may also be called a lowgrade glioma. Subependymal giant cell tumors are often asymptomatic.
Resection of subependymal giant cell astrocytoma guided by intraoperative magnetic resonance imaging and neuronavigation article in child s nervous system 297 february 20 with 9 reads. Brain magnetic resonance imaging revealed an approximately 3. Reportedly, 5% to 20% of tsc patients develop lowgrade cns lesions known as subependymal giant cell astrocytomas segas, which arise from the subependymal nodules 3, 4. In the current era of magnetic resonance imaging neuroimaging, many. Subependymal giant cell astrocytoma genetic and rare. Subependymal giant cell astrocytoma sega is a clinically benign brain tumor associated with tuberous sclerosis complex tsc. Subependymal giant cell astrocytoma sega is a clinically benign brain. There are still controversies on early diagnosis of the tumor. It can degenerate into sub ependymal giant cell astrocytomas in 510% of cases. Tuberous sclerosis complex tsc is a tumor suppressor syndrome caused by mutations in tsc1 or tsc2, encoding hamartin and tuberin, respectively. Pdf the diagnosis and treatment of subependymal giant cell. Subependymal giant cell astrocytoma wikimili, the free.
Imaging manifestations of a subependymal giant cell astrocytoma. Subependymal giant cell astrocytoma is a rare tumor that occurs in the wall of the lateral ventricle and foramen of monro and, rarely, in the third ventricle. Subependymal giant cell astrocytoma sega is a unique brain tumor arising in tuberous sclerosis complex tsc, an autosomal dominant. Subependymal giant cell astrocytoma radiology reference article. Intraoperative gdenhanced t1weighted mr images showing the probe tip. Subependymal giant cell astrocytomas segas are a common manifestation of tuberous sclerosis ts. Laser interstitial thermal therapy for subependymal giant cell. October 2010 approved for the treatment of patients with subependymal giant cell astrocytoma sega associated with tuberous sclerosis who require therapeutic intervention but are not candidates for curative surgical resection. They can be either asymptomatic or symptomatic due obstructive hydrocephalus, surgery treatment is often curative.
Ct and mr imaging of 20 patients with pathologically confirmed sega. It has high accuracy and may be a safer and more efficient imaging method for tuberous sclerosis complex patients who commonly undergo numerous mri examinations throughout their lifetime. Subependymal giant cell astrocytoma sega treatment update. These proteins act as a complex that inhibits mammalian target of rapamycin mtormediated cell growth and proliferation. Subependymal giant cell astrocytoma sega, sgca, or sgct is a lowgrade astrocytic brain tumor astrocytoma that arises within the ventricles of the brain. Imaging characteristics and growth of subependymal giant cell. In june 2012, an international tuberous sclerosis complex consensus conference was convened, during which an expert panel revised the diagnostic criteria and considered treatment options for subependymal giant cell astrocytomas.
They can be divided into those that are diffuse in growth the vast majority, generally having higher grade and poorer prognosis and those that are localized tend to have a lower grade and better prognosis. Subependymal giant cell astrocytoma radiology reference. Subependymal giant cell astrocytomas sgcas or alternatively segas are benign tumors who grade i, seen almost exclusively in young patients with. Although it is a lowgrade tumor, its location can potentially obstruct. Consistent nuclear expression of thyroid transcription factor 1 in subependymal giant cell astrocytomas suggests lineagerestricted histogenesis. Efficacy and safety of everolimus for subependymal giant cell. Subependymal giant cell astrocytomas are characteristic brain tumors. Subependymal nodules of brain something about medical imaging. Subependymal giant cell astrocytoma sega is a benign. In this presentation, clinical and radiological findings of subependymal giant cell astrocytoma and cortical tubers leading to new onset seizures will be discussed. Subependymal giant cell astrocytomas, which are slowgrowing, glioneuronal tumors typically arising near the foramen of monro, 5,6 develop in 5 to 20% of patients with the tuberous sclerosis. Seizures, increased intracranial hypertension and acute hydrocephalus are main clinical findings, while imaging studies such as ct andor mri are necessary diagnostic tools. These evolving tumors have a propensity to cause obstructive hydrocephalus, usually due to obstruction at the level of the foramen of monro. They are located along the ventricles and are mostly asymptomatic.
1060 1389 23 422 176 571 948 973 111 1386 626 770 102 903 916 633 993 1301 64 593 944 1074 1234 1062 450 138 220 532 901 207 1081 74 196 40 216 111 101 53 96 961 1212 1312 979